{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:32:29Z","timestamp":1759815149032},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T00:00:00Z","timestamp":1219708800000},"content-version":"vor","delay-in-days":3678,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:sec><jats:label \/><jats:p>Brandi L, Nielsen PK, Bro S, Daugaard H, Olgaard K (Rigshospitalet, University of Copenhagen, Denmark). Long\u2010term effects of intermittent oral alphacalcidol, calcium carbonate and low\u2010calcium dialysis (1.25 mmol L<jats:sup>\u22121<\/jats:sup>) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis. <jats:italic>J Intern Med<\/jats:italic> 1998; <jats:bold>244<\/jats:bold>: 121\u201331.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>(i) To examine the effect of alphacalcidol [1\u03b1(OH)D<jats:sub>3<\/jats:sub>] given as an oral dose twice weekly in combination with CaCO<jats:sub>3<\/jats:sub> and low\u2010calcium dialysis (1.25 mmol L<jats:sup>\u22121<\/jats:sup>) on the secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis (CAPD). (ii) To examine the changes in peritoneal mass transfer for calcium, phosphorus, magnesium, lactate, creatinine, urea, glucose, pH and albumin after shift to low\u2010calcium dialysis solution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>An open study in patients on CAPD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Renal division, Rigshospitalet, Copenhagen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects<\/jats:title><jats:p>Thirty\u2010nine patients were included and completed 12 weeks of treatment. Thirty of the patients completed 52 weeks of treatment. A peritoneal equilibrium test (PET) was performed in seven patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Following two sets of blood samples obtained as basal values the calcium concentration was reduced in the dialysis fluid from 1.75 mmol L<jats:sup>\u22121<\/jats:sup> to 1.25 mmol L<jats:sup>\u22121<\/jats:sup>. Increasing doses of oral 1\u03b1(OH)D<jats:sub>3<\/jats:sub> were then administered under careful control of p\u2010ionized calcium (p\u2010Ca<jats:sup>2+<\/jats:sup>) and p\u2010inorganic phosphate (p\u2010P<jats:sub>i<\/jats:sub>). Blood samples were obtained every 2\u20134 weeks for 52 weeks. PET was performed using standard dialysis fluid and 1 week later using low\u2010calcium dialysis fluid after a preceding overnight dwell. Two litres of glucose 22.7 mg mL<jats:sup>\u22121<\/jats:sup> were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Intact parathyroid hormone (PTH), p\u2010Ca<jats:sup>2+<\/jats:sup>, p\u2010P<jats:sub>i<\/jats:sub>, doses of CaCO<jats:sub>3<\/jats:sub>, doses of 1\u03b1(OH)D<jats:sub>3<\/jats:sub>, peritoneal mass transfer for calcium, inorganic phosphate, magnesium, lactate, creatinine, urea, glucose and albumin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty nine patients with initial PTH values 144 \u00b1 26 pg mL<jats:sup>\u22121<\/jats:sup> were followed for 12 weeks and 30 patients for 52 weeks. A negative calcium balance was induced after shifting to low\u2010calcium dialysis fluid. After 2 weeks of treatment a significant increase of PTH by approximately 60% and a small but significant decrease of p\u2010Ca<jats:sup>2+<\/jats:sup> was observed. After 12 weeks of treatment with increasing doses of 1\u03b1(OH)D<jats:sub>3<\/jats:sub> and CaCO<jats:sub>3<\/jats:sub>, PTH was again reduced to levels not significantly different from the initial values. After 52 weeks of treatment no deterioration of the secondary hyperparathyroidism was seen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A calcium concentration of 1.25 mmol L<jats:sup>\u22121<\/jats:sup> in the CAPD dialysate made it possible to reduce the amount of aluminium\u2010containing phosphate binder, to increase the doses of CaCO<jats:sub>3<\/jats:sub> and to use pulse oral 1\u03b1(OH)D<jats:sub>3<\/jats:sub> without causing severe hypercalcaemia in the patients. After a short elevation of PTH, the PTH levels remained at normal or near normal levels and the long\u2010term results clearly demonstrated that an aggravation of the secondary hyperparathyroidism could be inhibited.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2796.1998.00323.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:07:10Z","timestamp":1047449230000},"page":"121-131","source":"Crossref","is-referenced-by-count":7,"title":["Long\u2010term effects of intermittent oral alphacalcidol, calcium carbonate and low\u2010calcium dialysis (1.25 mmol L<sup>\u22121<\/sup>) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis"],"prefix":"10.1111","volume":"244","author":[{"family":"Brandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Olgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.64"},{"key":"e_1_2_6_3_2","first-page":"S92","article-title":"Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.","volume":"40","author":"Coburn J","journal-title":"Kid Int"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80977-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.176"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199207000-00105"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80832-8"},{"key":"e_1_2_6_8_2","first-page":"257","article-title":"Hyperparathyroidism in CAPD patients. Therapy with pulse oral calcitriol","volume":"9","author":"Juergensen PH","year":"1993","journal-title":"Adv Perit Dial"},{"key":"e_1_2_6_9_2","first-page":"260","article-title":"Pulse. Intravenous calcitriol therapy of secondary hyperparathyroidsm in peritoneal dialysis patients","volume":"9","author":"Wadhwa NK","year":"1993","journal-title":"Adv Perit Dial"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/089686089301300207","article-title":"Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients.","volume":"13","author":"Rolla D","year":"1993","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.68"},{"key":"e_1_2_6_12_2","first-page":"62","article-title":"Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.","volume":"8","author":"Arora N","year":"1992","journal-title":"Adv Perit Dial"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188732"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199407000-00006"},{"key":"e_1_2_6_15_2","first-page":"216","article-title":"Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.","volume":"40","author":"Fischer ER","year":"1993","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.223"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000189286"},{"key":"e_1_2_6_18_2","first-page":"138","article-title":"Peritoneal equilibration test.","volume":"3","author":"Twardowski Z","year":"1987","journal-title":"Perit Dial Bull"},{"key":"e_1_2_6_19_2","first-page":"E740","article-title":"Metabolism of intact parathyroid hormone in isolated perfused rat liver and kidney.","volume":"254","author":"Daugaard H","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-1-91"},{"key":"e_1_2_6_21_2","unstructured":"Practical Statistics for Medical ResearchLondon: Chapman and Hall 1991."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000187245"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/7.12.1219"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1177\/089686089301302S115","article-title":"Removal of phosphorus by peritoneal dialysis.","volume":"13","author":"Delmez JA","year":"1993","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1177\/089686089301302S114","article-title":". Osteodystrophy in continous ambulatory peritoneal dialysis.","volume":"13","author":"Brown CB","year":"1993","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/089686089101100406","article-title":"Short\u2010term effects of low\u2010calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients.","volume":"11","author":"Pagliari B","year":"1991","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1177\/089686089301302S117","article-title":"Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mm","volume":"13","author":"Weinreich T","year":"1993","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_28_2","first-page":"48","article-title":"Calcium mass transfer in peritoneal dialysis patients using 2.5 Meq L\u22121 Calcium Dialysate","volume":"37","author":"Piraino B","year":"1992","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/089686089301300311","article-title":"Calcium and Magensium Mass Transfer in Peritoneal Dialysis Patients using 1.25 mmol L\u22121 Calcium, 0.25 mmol L\u22121 magnesium dialysis fluid.","volume":"13","author":"Hutchison AJ","year":"1993","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.222"},{"key":"e_1_2_6_31_2","first-page":"240","article-title":"Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients.","volume":"14","author":"Gonella M","year":"1988","journal-title":"Miner Electrolyte Metab"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1998.00323.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00323.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2796.1998.00323.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00323.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:38:26Z","timestamp":1694414306000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.1998.00323.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1046\/j.1365-2796.1998.00323.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.1998.00323.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}